Hemodialysis treatment time: A fresh perspective

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 10, 2011, Pages 2522-2530

  Lacson Jr , Eduardo ^a   Brunelli, Steven M ^b  

^a Fresenius Medica Care   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; OUTCOME ASSESSMENT; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; WELLBEING;

FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMODIALYSIS, HOME; HUMANS; KIDNEY DISEASES; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; PATIENTS; QUALITY INDICATORS, HEALTH CARE; RENAL DIALYSIS;

EID: 80053900350     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00970211     Document Type: Article

References (107)

1. Johnson WJ, Zabransky RJ, Mueller GJ, Wagoner RD, Maher FT: Modifications in the assembly and sterilization of the Kiil dialyzer and Quinton-Scribner tank. Mayo Clin Proc 40: 462-472, 1965
2. Shibagaki M, Kolff WJ: In vitro and clinical studies of fluid removal with the Kiil dialyzer and subatmospheric-presure dialysate circuit. Cleve Clin Q 32: 157-163, 1965
3. De Palma JR: Adequate hemodialysis schedule. N Engl J Med 285: 353, 1971
4. Van Stone JC: Dialysis equipment and dialysate, past, present and the future. Semin Nephrol 17: 214-217, 1997
5. Rettig RA: The politics of health cost containment: End-stage renal disease. Bull N Y Acad Med 56: 115-138, 1980
6. Stewart RD, Cerny JC, Mahon HI: The capillary "kidney": Preliminary report. Med Bull 30:116-118, 1964
7. Gotch F, Lipps B, Weaver J Jr, Brandes J, Rosin J, Sargent J, Oja P: Chronic hemodialysis with the hollow fiber artificial kidney (HFAK). Trans Am Soc Artif Intern Organs 15: 87-96, 1969
8. Cheung AK, Leypoldt JK: The hemodialysis membranes: A historical perspective, current state and future prospect. Semin Nephrol 17: 196-213, 1997
9. Roy T, Ahrenholz P, Falkenhagen D, Klinkmann H: Volumetrically controlled ultrafiltration: Current experiences and future prospects. Int J Artif Organs 5: 131-135, 1982
10. Graefe U, Milutinovich J, Follette WC, Vizzo JE, Babb AL, Scribner BH: Less dialysis-induced morbidity and vascular 332-336, 1978
11. Viljoen M, Gold CH: Danger of haemodialysis using acetate dialysate in combination with a large surface area dialyser. S Afr Med J 56: 170-172, 1979
12. Man NK, Jehenne G, Funck-Brentano JL: Bicarbonate-containing dialysate: A critical study. Nephrologie 4: 161-165, 1983
13. Keshaviah P, Collins A: Rapid high-efficiency bicarbonate hemodialysis. ASAIO Trans 32: 17-23, 1986
14. Hilderson J, Ringoir S, van Waeleghem JP, van Egmond J, van Haelst JP, Schelstraete K: Short dialysis with a polyacrylonitrilmembrane (RP 6) without the use of a closed recirculating dialyzate delivery system. Clin Nephrol 4: 18-22, 1975
15. Alvarez-Ude F, Ward M, Elliott RW, Uldall PR, Wilkinson R, Appleton DR, Kerr DN, Petrella E, Gentile M, Romagnoni M, Orlandini G, Luciani L, Ferrandes C, D'Amico G: A comparison of short and long haemodialysis. Proc Eur Dial Transplant Assoc 12: 606-613, 1976
16. Trafford JA, Sharpstone P, Evans R, Ireland R: Evaluation of ultra-short dialysis. BMJ 1: 518-519, 1979
17. Chapman GV, Mahony JF, Farrell PC: A crossover study of short time dialysis. Clin Nephrol 13: 78-84, 1980
18. Rotellar E, Martinez E, Samso JM, Barrios J, Simo R, Mulero JF, Perez D, Bandres S, Pinol J: Why dialyze more than 6 hours a week? Trans Am Soc Artif Intern Organs 31: 538-545, 1985
19. Bosl R, Shideman JR, Meyer RM, Buselmeier TJ, von HB, Kjellstrand CM: Effects and complications of high efficiency dialysis. Nephron 15: 151-160, 1975
20. Ward RA, Farrell PC, Tiller DJ, Horvath JS, Freeman JM: A clinical evaluation of large-area short-time haemodialysis. Aust N Z J Med 6: 288-291, 1976
21. Sellars L, Robson V, Wilkinson R: Sodium retention and hypertension with short dialysis. BMJ 1: 520-521, 1979
22. Teschan PE, Ginn HE, Bourne JR, Ward JA, Schaffer JD: A prospective study of reduced dialysis. ASAIO J 6: 108-122, 1983
23. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176-1181, 1981
24. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526-534, 1985
25. Wauters JP, Bercini-Pansiot S, Gilliard N, Stauffer JC: Short hemodialysis: long-term mortality and morbidity. Artif Organs 10: 182-184, 1986
26. Rubin JE, Berlyne GM: Long-term follow-up of patients on short-time dialysis. ASAIO Trans 33: 540-541, 1987
27. Charra B, Calemard E, Cuche M, Laurent G: Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 33: 96-99, 1983
28. Gutierrez A, Alvestrand A, Bergstrom J, Beving H, Lantz B, Henderson LW: Biocompatibility of hemodialysis membranes: A study in healthy subjects. Blood Purif 12: 95-105, 1994
29. Levin NW, Zasuwa G: Relationship between dialyser type and signs and symptoms. Nephrol Dial Transplant 8[Suppl 2]: 30-39, 1993
30. Parker TF III, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM: Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 49: 551-556, 1996
31. Pagel MD, Ahmad S, Vizzo JE, Scribner BH: Acetate and bicarbonate fluctuations and acetate intolerance during dialysis. Kidney Int 21: 513-518, 1982
32. Silverberg DS, Bettcher KB, Dossetor JB, Overton TR, Holick MF, DeLuca HF: Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy. CMAJ 112: 193-195, 1975
33. Cunningham J: What is the optimal regimen for vitamin D? Kidney Int Suppl 73: S59-S64, 1999
34. Friedman EA: An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic kidney disease. Kidney Int 68: Suppl S2-S6, 2005
35. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16: 1115-1125, 2005
36. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR: Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a phase III multicenter clinical trial. Ann Intern Med 111: 992-1000, 1989
37. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH:Mortality and duration of hemodialysis treatment. JAMA 265: 871-875, 1991
38. Blagg CR: The US Renal Data System and the Case-Mix Severity Study. Am J Kidney Dis 21: 106-108, 1993
39. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS: Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15: 451-457, 1990
40. Held PJ, Blagg CR, Liska DW, Port FK, Hakim R, Levin N: The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int Suppl 38: S16-S21, 1992
41. The Morbidity, Mortality and Prescription of Dialysis Symposium Proceedings. Dallas, Texas, September 15-17, 1989. Am J Kidney Dis 15: 375-515, 1990
42. Collins AJ, Kjellstrand CM: Shortening of the hemodialysis procedure and mortality in "healthy" dialysis patients. ASAIO Trans 36: M145-M148, 1990
43. Dumler F, Stalla K, Mohini R, Zasuwa G, Levin NW: Clinical experience with short-time hemodialysis. Am J Kidney Dis 19: 49-56, 1992
44. Capelli JP, Kushner H, Camiscioli T, Chen SM, Stuccio-White NM: Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling: A critical appraisal of shortening dialysis times. Am J Nephrol 12: 212-223, 1992
45. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23: 661-669, 1994
46. Parker TF III, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 23: 670-680, 1994
47. Gotch FA, Levin NW, Port FK, Wolfe RA, Uehlinger DE: Clinical outcome relative to the dose of dialysis is not what you think: The fallacy of the mean. Am J Kidney Dis 30: 1-15, 1997
48. Daugirdas JT, Depner TA, Gotch FA, Greene T, Keshaviah P, Levin NW, Schulman G: Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 52: 1395-1405, 1997
49. Cappello A, Grandi F, Lamberti C, Santoro A: Comparative evaluation of different methods to estimate urea distribution volume and generation rate. Int J Artif Organs 17: 322-330, 1994
50. Spiegel DM, Baker PL, Babcock S, Contiguglia R, Klein M: Hemodialysis urea rebound: The effect of increasing dialysis efficiency. Am J Kidney Dis 25: 26-29, 1995
51. Depner TA: Quantifying hemodialysis. Am J Nephrol 16: 17-28, 1996
52. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
53. Eloot S, van BW, Dhondt A, Van de Wynkele H, Glorieux G, Verdonck P, Vanholder R: Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 73: 765-770, 2008
54. Eloot S, Torremans A, De Smet R, Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R: Kinetic behavior of urea is different from that of other watersoluble compounds: The case of the guanidino compounds. Kidney Int 67: 1566-1575, 2005
55. Scharfetter H, Wirnsberger G, Hutten H, Holzer H: Development and critical evaluation of an improved comprehensive multicompartment model for the exchange processes during hemodialysis. Biomed Tech 40: 54-63, 1995
56. Schneditz D, Daugirdas JT: Compartment effects in hemodialysis. Semin Dial 14: 271-277, 2001
57. Luik AJ, Charra B, Katzarski K, Habets J, Cheriex EC, Menheere PP, Laurent G, Bergstrom J, Leunissen KM: Blood pressure control and hemodynamic changes in patients on long time dialysis treatment. Blood Purif 16: 197-209, 1998
58. Ly J, Chan CT: Impact of augmenting dialysis frequency and duration on cardiovascular function. ASAIO J 52: e11-e14, 2006
59. Bogaard HJ, de Vries JP, de Vries PM: Assessment of refill and hypovolaemia by continuous surveillance of blood volume and extracellular fluid volume. Nephrol Dial Transplant 9: 1283-1287, 1994
60. Port FK, Johnson WJ, Klass DW: Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int 3: 327-333, 1973
61. Gotch FA, Lam MA, Prowitt M, Keen M: Preliminary clinical results with sodium-volume modeling of hemodialysis therapy. Proc Clin Dial Transplant Forum 10: 12-17, 1980
62. Akcahuseyin E, Nette RW, Vincent HH, van Duyl WA, Krepel H, Weimar W, Zietse R: Simulation study of the intercompartmental fluid shifts during hemodialysis. ASAIO J 46: 81-94, 2000
63. Flanigan M: Dialysate composition and hemodialysis hypertension. Semin Dial 17: 279-283, 2004
64. Ritz E, Pablick-Deetjen J, Zeier M, Amann K: Blood pressure on dialysis: An ongoing controversy. Saudi J Kidney Dis Transpl 13: 1-13, 2002
65. Donauer J: Hemodialysis-induced hypotension: Impact of technologic advances. Semin Dial 17: 333-335, 2004
66. Davenport A, Cox C, Thuraisingham R: Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int 73: 759-764, 2008
67. Tisler A, Akocsi K, Borbas B, Fazakas L, Ferenczi S, Gorogh S, Kulcsar I, Nagy L, Samik J, Szegedi J, Toth E, Wagner G, Kiss I: The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant 18: 2601-2605, 2003
68. Shoji T, Tsubakihara Y, Fujii M, Imai E: Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66: 1212-1220, 2004
69. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
70. Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G: Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis: a 5-year prospective observational multicentre study. Nephrol Dial Transplant 22: 3547-3552, 2007
71. Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2010
72. Brunet P, Saingra Y, Leonetti F, Vacher-Coponat H, Ramananarivo P, Berland Y: Tolerance of haemodialysis: a randomized cross-over trial of 5-h versus 4-h treatment time. Nephrol Dial Transplant 11[Suppl 8]: 46-51, 1996
73. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, Leunissen KM, Laurent G, Bergstrom J: Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 14: 369-375, 1999
74. McGregor DO, Buttimore AL, Lynn KL, Nicholls MG, Jardine DL: A comparative study of blood pressure control with short in-center versus long home hemodialysis. Blood Purif 19: 293-300, 2001
75. Troidle L, Hotchkiss M, Finkelstein F: A thrice weekly in-center nocturnal hemodialysis program. Adv Chronic Kidney Dis 14: 244-248, 2007
76. Lacson E Jr, Wang W, Lester K, Ofsthun N, Lazarus JM, Hakim RM: Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol 5: 220-226, 2010
77. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL: Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis 44: 22-26, 2004
78. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL: Haemodialysis vascular access problems in Canada: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 21: 721-728, 2006
79. Hofstra L, Bergmans DC, Leunissen KM, Hoeks AP, Kitslaar PJ, Tordoir JH: Prosthetic arteriovenous fistulas and venous anastomotic stenosis: Influence of a high flow velocity on the development of intimal hyperplasia. Blood Purif 14: 345-349, 1996
80. Haruguchi H, Teraoka S: Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review. J Artif Organs 6: 227-235, 2003
81. Osterberg K, Mattsson E: Intimal hyperplasia in mouse vein grafts is regulated by flow. J Vasc Res 42: 13-20, 2005
82. Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, Samaha A, Munda R: Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis 50: 782-790, 2007
83. Lacson E Jr, Wang W, Lester K, Ofsthun N, Lazarus JM, Hakim RM: Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol 2009
84. Marshall MR, Byrne BG, Kerr PG, McDonald SP: Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 69: 1229-1236, 2006
85. Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van WD, Greenland S, Kalantar-Zadeh K: Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 55: 100-112, 2010
86. Brunelli SM, Chertow GM, Ankers ED, Lowrie EG, Thadhani R: Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int 77: 630-636, 2010
87. Ok E, Duman S, Asci G, Tumuklu M, Onen SO, Kayikcioglu M, Toz H, Adam SM, Yilmaz M, Tonbul HZ, Ozkahya M: Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: A prospective, case-controlled study. Nephrol Dial Transplant 2010
88. Lacson E, Xu J, Lester K, Ofsthun N, Lindsay R, Suri R, Nesrallah G, Lazarus M, and Hakim R: Comparison of mortality risk between incenter nocturnal and conventional hemodialysis. http://www.kidney.org/news/meetings/clinical/abstract/CM10_Abstracts.cfm, 286. 2010. National Kidney Foundation. Accesssed April 19, 2011.
89. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287-2300, 2010
90. Kjellstrand C, Buoncristiani U, Ting G, Traeger J, Piccoli G, Sibai-Galland R, Young B: Survival with short daily hemodialysis: Association of time, site, and dose of dialysis. Hemodial Int 14: 464-470, 2010
91. Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb- Rumyantzev AS, Hoy CD, Lockridge RS Jr, Miller BW, Eggers PW, Kutner NG: Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: A USRDS study. Kidney Int 76: 984-990, 2009
92. Pipkin M, Eggers PW, Larive B, Rocco MV, Stokes JB, Suri RS, Lockridge RS Jr: Recruitment and training for home hemodialysis: Experience and lessons from the nocturnal dialysis trial. Clin J Am Soc Nephrol 5: 1614-1620, 2010
93. Lacson E Jr, Diaz-Buxo JA: Daily and nocturnal hemodialysis: How do they stack up? Am J Kidney Dis 38: 225-239, 2001
94. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53: 1399-1404, 1998
95. Lockridge RS Jr, Spencer M, Craft V, Pipkin M, Campbell D, McPhatter L, Albert J, Anderson H, Jennings F, Barger T: Nocturnal home hemodialysis in North America. Adv Ren Replace Ther 8: 250-256, 2001
96. Schwartz DI, Pierratos A, Richardson RM, Fenton SS, Chan CT: Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease. Clin Nephrol 63: 202-208, 2005
97. Tang HL, Wong JH, Poon CK, Chu KH, Lee W, Fung SK, Chau KF, Li CS, Tong KL: One year experience of nocturnal home haemodialysis with an alternate night schedule in Hong Kong. Nephrology 2010
98. Charra B: From adequate to optimal dialysis long 3 _ 8 hr dialysis: A reasonable compromise. Nefrologia 25 Suppl 2: 19-24, 2005
99. Bugeja A, Dacouris N, Thomas A, Marticorena R, McFarlane P, Donnelly S, Goldstein M: In-center nocturnal hemodialysis: Another option in the management of chronic kidney disease. Clin J Am Soc Nephrol 4: 778-783, 2009
100. David S, Kumpers P, Eisenbach GM, Haller H, Kielstein JT: Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. Nephrol Dial Transplant 24: 2232-2240, 2009
101. Thomas A, Chan A, Hunks MB, Zheng J: Providing an incentre nocturnal hemodialysis program: The pearls and pitfalls. CANNT J 17: 39-41, 2007
102. Ramkumar N, Beddhu S, Eggers P, Pappas LM, Cheung AK: Patient preferences for in-center intense hemodialysis. Hemodial Int 9: 281-295, 2005
103. Cafazzo JA, Leonard K, Easty AC, Rossos PG, Chan CT: Patient- perceived barriers to the adoption of nocturnal home hemodialysis. Clin J Am Soc Nephrol 4: 784-789, 2009
104. Medicare program: End-stage renal disease prospective payment system. Final rule. Fed Regist 75: 49029-49214, 2010
105. Bosch JP, Luckenbill L: Capitation in nephrology: The time has come. Adv Ren Replace Ther 4: 325-331, 1997
106. Nissenson AR: Models of capitated payment for endstage renal disease. Am J Med 110: 504-505, 2001
107. Lowell KH, Bertko J: The Accountable Care Organization (ACO) model: Building blocks for success. J Ambul Care Manage 33: 81-88, 2010